Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Geneart AG (OJ:G6A) - Ernst & Young honours Germany's best mid-tier companies - Impressive growth rates and high innovative strength lead GENEART AG's team into the final - Prestigious business award will be presented at the Alte Oper Frankfurt on October 9, 2008.
Regensburg, October 08, 2008 -GENEART AG, world market leader for gene synthesis and expert in Synthetic Biology has reached the "Entrepreneur of the Year 2008"-final for the second consecutive time. This award honours entrepreneurial top performances, and only Germany's most innovative companies with the strongest growth numbers reach the final.
The prize which has been awarded to Germany's best entrepreneurial mid-sized companies for the twelfth consecutive time by the auditing and consulting company Ernst & Young, has achieved high esteem due to its demanding entrance criteria. The candidates' performances are not only validated by the respective company's key figures but also during a personal discussion with an independent jury consisting of top-class experts. The winners out of the 65 finalists from five categories will be announced during a ceremonial award presentation at the Alte Oper Frankfurt in the evening of October 9, 2008. In addition, all finalists will be honoured and accepted into the Entrepreneur-of-the-Year club, the Hall of Fame for entrepreneurs in Germany.
GENEART, the publicly listed global market leader for gene synthesis and expert in Synthetic Biology, managed to average an annual increase of sales of approximately 60 % since its foundation. Again for 2008, a significant increase in sales is expected. Today, GENEART and its over 190 employees provide key technologies that allow a significantly faster and more cost effective access to genes than traditional techniques of molecular biology. Pharmaceutical companies for instance profit from this in their development of drugs and vaccines. "We are delighted to be honoured again as finalist in the "Entrepreneur of the Year 2008" contest. This award acknowledges our company and business strategy focusing on sustainable growth", stated Christian Ehl, CEO of GENEART AG.
Frank Ostermair Better Orange IR & HV AG Haidelweg 48 81241 Munich Germany Phone: +49-(0)89-8896906-10 Fax: +49-(0)89-8896906-66 info@better-orange.de www.better-orange.de
Legal Information This document may contain estimates, prognoses and opinions about company plans and objectives, products or services, future results, opinions about these results or opinions leading up to these results. All these projections into the future are subject to risk, uncertainty and unforeseeable change outside the control of the GENEART Group. Many factors may lead to actual results, which considerably deviate from the given projections for these results.
About GENEART AG: In 2000, GENEART entered the gene synthesis market and has since become the global market leader. Today, the company is one of the leading specialists in the Synthetic Biology field. Experts at GENEART provide key technologies for the development and production of new therapeutics and vaccines. Customers also take advantage of GENEART services to customize enzyme attributes, such as the attributes of enzymes used as detergent additives, and to construct bacteria, which produce complex biopolymers or break down polymers, such as synthetics, petroleum components, etc. Our production and service spectrum spans a wide range, from the production of synthetic genes according to DIN EN ISO 9001-2000, to the creation of gene libraries in the combinatorial biology, to the development and production of DNA-based biologically active substances. The GENEART AG in Regensburg (Germany) and the subsidiaries GENEART Inc. in Toronto (Canada) and GENEART Inc. in San Francisco (USA) employ more than 190 people. Since May 2006, GENEART is listed on the German Stock Exchange.
About the contest "Entrepreneur of the Year": Ernst & Young organizes the contest for companies "Entrepreneur of the Year" in 50 countries around the world. In Germany the prize will be awarded for the twelfth time in 2008. The award identifies and honours entrepreneurial top performances. An independent jury consisting of high-level entrepreneurs and scientists chooses the "Entrepreneur of the Year" in the categories manufacturing, trade, services, information and communication technology/media as well as start-ups. Renowned businesses and media companies support the contest as partners. These include BMW, IKB Deutsche Industriebank, Capgemini, Frankfurter Allgemeine Zeitung and Manager Magazin.
About Ernst & Young: Ernst & Young AG Auditors and Tax Consultants with its main offices in Stuttgart is on of the three large auditing and consulting companies in Germany and independent member of the international network of Ernst & Young Global*. Ernst & Young is the No. 1 in the field of tax consulting among German tax consulting and accounting service providers. Ernst & Young employs approx. 6,100 staff at 21 locations and reached sales of EUR 1.08 billion during its financial year 2006/2007. The approx. 130,000 employees of Ernst & Young Global* generated sales of USD 21.1 billion during the financial year of 2006/2007.
In Germany, the Ernst & Young Group provides a comprehensive portfolio of services not only to large but also to mid-sized companies: auditing, tax consulting as well as transaction, management, risk and real estate consulting.
